Peg-IFNα: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Peg-IFNα

• A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
  NCT07069569 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 14 locations
• A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
  NCT06425341 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
  NCT05771402 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• A Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
  NCT06650852 · Phase: Phase 2 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 14 locations
• ASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
  NCT07573943 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 1 location
• Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon
  NCT06696664 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Peg-IFNα?

6 recruiting trials across 5 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.